← All reports

The Supreme Court is being asked to intervene to prevent the Fifth Circuit's ruling from blocking the FDA's policy that allows the mailing of mifepristone, a medication abortion drug.

HealthcareLawPoliticsMay 2, 2026score 0.742 posts · 7 replies across 2 instances
The thread discusses a legal challenge regarding the mailing of mifepristone, a medication abortion drug, as a pharmaceutical company seeks a Supreme Court stay of a Fifth Circuit ruling that would block the FDA's policy allowing such mailing. This legal action highlights the ongoing debate over access to medication abortion and regulatory policies.

Claims

The Supreme Court is being asked to intervene to prevent the Fifth Circuit's ruling from blocking the FDA's policy that allows the mailing of mifepristone, a medication abortion drug.
Parent: HealthcareEntity: MifepristoneImpact: negativeDate: May 2, 2026Target: The Supreme Court's decision on whether to block the Fifth Circuit's ruling against the FDA's policy allowing the mailing of mifepristone.

Source posts

@[email protected]
BREAKING: Danco Laboratories, maker of Mifeprex, goes to the Supreme Court, seeking an immediate stay of the Fifth Circuit's Friday mifepristone ruling. Under the Fifth Circuit ruling, FDA's rule that allowed mailing of the medication abortion drug is to be blocked. More to come: https://www.lawdork.com/
6 boosts · 0 favs · 3 replies · May 2, 2026
@[email protected]
BREAKING: Mifepristone is back at the Supreme Court in case over mailing the medication abortion drug. After a Fifth Circuit ruling Friday that would end the mailing of mifepristone, a drugmaker asked SCOTUS to act immediately to keep the FDA policy allowing mailing in place. New, at Law Dork: https://www.lawdork.com/p/mifepristone-supreme-court-return-mailing
13 boosts · 0 favs · 4 replies · May 2, 2026